Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 11/02/16
End: 06/10/24
Due: 06/10/25
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 06/30/16
Due: 06/30/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction. | NCT01175200 | Ascopharm Groupe Novasco | user2@example.com | None | 2010-09-30 | 2012-07-31 | 2013-07-31 | - | - | 2025-07-14 |
| ACL Versus ALL + ACL Study | NCT03740022 | Ascopharm Groupe Novasco | user2@example.com | None | 2016-11-02 | 2024-06-10 | 2025-06-10 | - | - | 2025-07-14 |
| Efficacy and the Safety Study of RD94 in Patients With Endodontic Care | NCT01737229 | Ascopharm Groupe Novasco | user2@example.com | None | 2010-01-31 | 2013-04-30 | 2014-04-30 | - | - | 2025-07-14 |
| Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer | NCT01728532 | Ascopharm Groupe Novasco | user2@example.com | None | 2012-06-30 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |